Skip Ribbon Commands
Skip to main content
Menu
Clin Assoc Prof Chin Chee Tang

Clin Assoc Prof Chin Chee Tang

​MBChB (Honours)(Edinburgh), MRCP(UK), FAMS

Senior Consultant

National Heart Centre Singapore

Specialty: Cardiology

Sub-specialties: Interventional Cardiology

Clinical Appointments

  • Senior Consultant Department of Cardiology National Heart Centre SingaporeNational Heart Centre Singapore
  • Chief Risk Officer, Risk Management National Heart Centre SingaporeNational Heart Centre Singapore
  • Director, Coronary Intervention Service National Heart Centre SingaporeNational Heart Centre Singapore

Academic Appointments

  • Academic Vice Chair (Faculty and Professional Development) SingHealth Duke-NUS Cardiovascular Sciences Academic Clinical Programme

Profile

Clinical Associate Prof Chin Chee Tang is a Senior Consultant with the Department of Cardiology, and the Director of Coronary Intervention Service at the National Heart Centre Singapore (NHCS).

His sub-specialty interest is in interventional cardiology and he performs percutaneous coronary interventions both in the elective and emergency settings. In addition, he performs catheter-based renal sympathetic denervation for the management of patients with uncontrolled high blood pressure.

Clin Assoc Prof Chin is actively involved in clinical research. In 2010, he completed his Fellowship at the Duke Clinical Research Institute, United States, with a special emphasis on clinical trials and outcomes research. He presently has a joint appointment as Clinical Associate Professor at the Duke-NUS Medical School and continues to collaborate on national, and international clinical studies and trials. He continues to publish actively in international peer-reviewed publications.

He is the Academic Vice-Chair (Faculty and Professional Development) of the SingHealth Duke-NUS Cardiovascular Sciences – Academic Clinical Programme, Chair of the Clinical Competency Committee and a Core Faculty Member of the Cardiology Senior Residency Programme.

He has been the Chief Risk Officer at NHCS since 2018.

Education

  • MRCP(UK), Royal College of Physicians, United Kingdom, 2002
  • MBChB (with Honours), University of Edinburgh, United Kingdom, 1999

Professional Appointments and Committee Memberships

  • Director, Coronary Intervention Service, Jan 2022 to Present
  • Senior Consultant, Department of Cardiology, National Heart Centre Singapore
  • Chief Risk Officer, Risk Management, National Heart Centre Singapore, Aug 2018 to Present
  • Clinical Associate Professor, Duke-NUS Medical School
  • Fellow of Academy of Medicine, Singapore, since 2007
  • Member of Singapore Cardiac Society
  • Member of British Medical Association
  • Assistant Professor, Duke-NUS Medical School - to 2018
  • Senior Clinical Lecturer, NUS Yong Loo Lin School of Medicine

Awards

  • Singapore Health Quality Service Award (SHQSA) (STAR), 2016
  • RISE Awards – Outstanding Faculty Award, 2015
  • SingHealth Publish! Award (Medical Research), 2015
  • RISE Awards – Outstanding Faculty Award, 2014
  • National Heart Centre Singapore Service Award (Silver), 2014
  • Singapore Health Quality Service Award (SHQSA) (GOLD), 2014
  • Singapore Health Quality Service Award (SHQSA) (Silver), 2013
  • National Heart Centre Singapore Long Service Award, 2013
  • National Heart Centre Singapore Productivity Award, 2013
  • SingHealth Health Manpower Development Plan (HMDP) Fellowship in Cardiac Database Development, Quality and Outcomes in Interventional and Acute Coronary Care, 2009
  • National Heart Centre Singapore Service Award (Bronze), 2009
  • National Heart Centre Singapore Service Award (Bronze), 2008

Research Interests

  • ​The use of large patient databases to examine clinical outcomes and quality

Publications

  • Combined diagnostic performance of coronary computed tomography angiography and computed tomography derived fractional flow reserve for the evaluation of myocardial ischemia: A meta-analysis. Tan XW, Zheng Q, Shi L, Gao F, Allen JC Jr, Coenen A, Baumann S, Schoepf UJ, Kassab GS, Lim ST, Wong AS, Tan JW, Yeo KK, Chin Chee Tang, Ho KW, Tan SY, Chua TS, Chan ES, Tan RS, Zhong L. Int J Cardiol. 2017 Jun 1;236:100-106. 
  • The effect of a nurse-led telephone-based care coordination program on the follow-up and control of cardiovascular risk factors in patients with coronary artery disease. Wong Ningyan, Chua Terrance SJ, Gao Fei, Sim Sok Tiang, Matchar David, Wong Sung Lung, Yeo Khung Keong, Tan Wei Chieh, Chin Chee Tang. Int J Qual Health Care. 2016; 28 (6): 758-763.
  • Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease. Koh Angela S; Gao Fei; Chin Chee Tang; Keng Felix Y J; Tan Ru-San; Chua Terrance S J. Journal of Nuclear Cardiology 2016; 23(3):366-378
  • Warfarin related nephropathy: a case report and review of the literature. Ng Chee Yong; Tan Chieh Suai; Chin Chee Tang; Lim See Lim; Zhu Ling; Woo Keng Thye; Tan Puay Hoon. BMC nephrology 2016; 17(15):N.A-N.A
  • Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial. Chin Chee Tang; Neely Benjamin; Magnus Ohman E; Armstrong Paul W; Corbalán Ramón; White Harvey D; Prabhakaran Dorairaj; Winters Kenneth J; Fox Keith A A; Roe Matthew T. Stroke; a journal of cerebral circulation 2016; 47(4):1135-1139
  • Catastrophic health expenditure on acute coronary events in Asia: a prospective study. Jan Stephen; Lee Stephen W-L; Sawhney Jitendra P S; Ong Tiong K; Chin Chee Tang; Kim Hyo-Soo; Krittayaphong Rungroj; Nhan Vo T; Itoh Yohji; Huo Yong. Bulletin of the World Health Organization 2016; 94(3):193-200
  • Effect of prior clopidogrel use on outcomes in medically managed acute coronary syndrome patients. Chin Chee Tang; Boden William E; Roe Matthew T; Neely Benjamin; Neely Megan L; Leiva-Pons Jose L; Corbalán Ramón; Gottlieb Shmuel; Dalby Anthony J; Armstrong Paul W; Prabhakaran Dorairaj; Fox Keith A A; White Harvey D; Ohman E Magnus; Winters Kenneth J; Schiele Francois. Heart (British Cardiac Society) 2016; 102(15):1221-1999 
  • Chest Pain, Something is Not Right…Or Left. Ruan Wen; Wong Aaron S L; Tan Swee Yaw; Tan Ru San; Chin Chee Tang. Annals of the Academy of Medicine, Singapore 2015; 44(3):114-115 Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities
  • From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study. Mathews Robin; Peterson Eric D; Honeycutt Emily; Chin Chee Tang; Effron Mark B; Zettler Marjorie; Fonarow Gregg C; Henry Timothy D; Wang Tracy Y. Circulation. Cardiovascular quality and outcomes 2015; 8(4):347-356 
  • Rationale, Design, and Baseline Characteristics of the EPICOR Asia Study (Long-term follow-up of antithrombotic management patterns In Acute CORonary Syndrome patients in Asia). Huo Yong; Lee Stephen W-L; Sawhney Jitendra P S; Kim Hyo-Soo; Krittayaphong Rungroj; Nhan Vo T; Alonso-Garcia Angeles; Han Ya Ling; Ge Junbo; Chin Chee Tang; Ong Tiong K; Jan Stephen; Itoh Yohji; Vega Ana Maria; Pocock Stuart. Clinical cardiology 2015; 38(9):511-519 
  • Risk factors for cardiovascular events among Asian patients without pre-existing cardiovascular disease on the renal transplant wait list. Ningyan Wong; Chee Tang Chin; Ping Sing Tee; Lay Wai Khin; Koh Angela S; Shern Kee Yi; Terence ; Chieh Tan Wei; Jack. ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology 2015; 23(1):N.A-N.A 
  • Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction. Chin Chee Tang; Wang Tracy Y; Chen Anita Y; Mathews Robin; Alexander Karen P; Roe Matthew T; Peterson Eric D. American Heart Journal 2014; 167(1):36-42.e1
  • Comparison of percutaneous coronary intervention for previously treated versus de novo culprit lesions in acute myocardial infarction patients: insights from the National Cardiovascular Data Registry. Chin Chee Tang; Messenger John C; Dai David; McCoy Lisa A; Kutcher Michael A; Anderson H Vernon; Roe Matthew T; Wang. Tracy Y. American Heart Journal 2014; 167(3):393-400.e1
  • Pilot prospective study of therapeutic hypothermia for treatment of post-cardiac arrest patients. Ng M, Wong AS, Chew HC, Shahidah N, Pek PP, Poh J, Chin CT, Chua TS, Ong ME. International Journal of Cardiology. 2014 Mar 21. pii: S0167-5273(14)00568-3. doi: 10.1016/j.ijcard.2014.03.132 
  • Differences in late cardiovascular mortality following acute myocardial infarction in three major Asian ethnic groups. de Carvalho LP, Gao F, Chen Q, Hartman M, Sim LL, Koh TH, Foo D, Chin CT, Ong HY, Tong KL, Tan HC, Yeo TC, Yew CK, Richards AM, Peterson ED, Chua T, Chan MY. European Heart Journal Acute Cardiovascular Care. 2014 Mar 5.
  • Comparison of percutaneous coronary intervention for previously-treated versus de novo culprit lesions in acute myocardial infarction patients: Insights from the National Cardiovascular Data Registry®. Chin CT, Messenger J, Dai D, McCoy LA, Kutcher MA, Anderson HV, Roe MT, Wang TY. American Heart Journal. 2014;167(3):393-400
  • Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction. Chin CT, Wang TY, Chen AY, Mathews R, Alexander KP, Roe MT, Peterson ED. American Heart Journal. 2014; 167(1): 36-42. 
  • A case of aortic regurgitation and hypotension. Chan LLH, and Chin CT. International Journal of Angiology. 2013; 22: 263-266. 
  • Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective. Chin CT, Mellstrom C, Chua TSJ, Matchar DB. Singapore Medical Journal. 2013; 54(3): 169-175 • Syphilitic coronary artery ostial stenosis presenting with acute myocardial infarction. Ng CT, Chin CT, Ching CK. Heart. 2013; 99(4):290.
  • Differences in late cardiovascular mortality following acute myocardial infarction among three major Asian ethnicities. Carvalho L, Gao F, Chen Q, Hartman M, Sim LL, Koh TH, Foo D, Chin CT, et al. Journal of the American College of Cardiology. 2013;61(10_S):. doi:10.1016/S0735-1097(13)61572-7
  • Risk stratification and outcomes of patients with prior coronary artery stenting undergoing noncardiac surgery. Goodman A, Chenier M, Hornsby K, Anderson L, Goodwin B, Faridi K, Chin CT, et al. Journal of the American College of Cardiology. 2012;60(17_S):doi:. 10.1016/j.jacc.2012.08.595
  • Medication nonadherence among patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights from the TRANSLATE-ACS Study. Mathews R, Peterson E, Honeycutt E, Chin CT, Ryan K, Effron M, et al. Journal of the American College of Cardiology. 2012;59(13s1):E1814-E1814. doi:10.1016/S0735-1097(12)61815-4
  • Comparison of the prognostic value of peak CK-MB and troponin levels among patients with acute myocardial infarction: A report from the Acute Coronary Treatment and Intervention Outcomes Network Registry®–Get With The Guidelines™. Chin CT, Wang TY, Li S, Wiviott SD, deLemos JA, Kontos MC, Peterson ED, Roe MT. Clinical Cardiology. 2012; 35(7): 424-9.
  • Trends and predictors of length of stay after primary percutaneous coronary intervention: A report from the CathPCI Registry®. Chin CT, Weintraub W, Dai D, Mehta R, Rumsfeld JS, Anderson HV, Messenger JC, Kutcher MA, Peterson ED, Brindis RG, Rao SV. American Heart Journal. 2011; 162(6): 1052-61.
  • Treatment with adenosine diphosphate receptor inhibitors—Longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research. Chin CT, Wang TY, Anstrom KJ, Zhu B, Maa J-F, Messenger JC, Ryan KA, Davidson-Ray L, Zettler M, Effron MB, Mark DB, Peterson ED. American Heart Journal. 2011; 162(5): 844-51.
  • Risk adjustment for in-hospital mortality for contemporary acute myocardial infarction patients: the ACTION Registry®–GWTG™ Acute Myocardial Infarction Mortality Model and Risk Score. Chin CT, Chen AY, Wang TY, Alexander KP, Mathews R, Rumsfeld JS, Cannon CP, Fonarow GC, Peterson ED, Roe MT. American Heart Journal. 2011; 161(1): 113-122.e2
  • In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: Derivation and validation of a model from the ACTION Registry®-GWTG™. Mathews R, Peterson ED, Chen AY, Wang TY, Chin CT, Fonarow GC, Cannon CP, Rumsfeld JS, Roe MT, Alexander KP. American Journal of Cardiology. 2011; 107(8): 1136-1143. 
  • Controlled hypothermia in post-resuscitation management: What is so cool about it? Chin CT and Wong A. Singapore Medical Journal. 2011; 52(8): 603-606.
  • Current and emerging therapies for stroke prophylaxis in atrial fibrillation. Lim ETS, Yap J, Chin CT. Clinical Investigation. 2011; 1(7): 1019-1037.
  • Severe Unexplained Heart Failure in a Young Person. Moe MM, Koh A, Chin CT. Kardiologia Polska. 2010; 68(12): 1374-5.
  • Improving door-to-balloon times in Asia for acute ST elevation myocardial infarction via direct activation by emergency physicians of percutaneous coronary intervention. Ong ME, Wong AS, Chan KP, Bergin AR, Sultana P, Lim SH, Chua TS, Lim ST, Chin CT, Pek PP, Venkataraman A. International Journal of Cardiology. 2010; 145(3): 613-4.
  • Frequency and Predictors of Drug-Eluting Stent Use in Saphenous Vein Bypass Graft Percutaneous Coronary Interventions: A Report from the American College of Cardiology National Cardiovascular Data Cath PCI Registry. Brilakis ES, Wang TY, Rao SV, Banerjee S, Goldman S, Shunk K, Holmes DR Jr, Dai D, Chin CT, Harding TM, Roe MT. Journal of the American College of Cardiology: Cardiovascular Interventions. 2010; 3 (10): 1068-73.
  • Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, Lokhnygina Y, Brown E, Armstrong PW, White HD, Ohman EM. American Heart Journal. 2010; 160 (1): 16-22.e1
  • Risk assessment models in acute coronary syndromes and their applicability in Singapore. Chin CT, Chua T, Lim ST. Annals Academy of Medicine Singapore. 2010; 39(3): 216-220.
  • Reducing door-to-balloon time in ST-segment elevation myocardial infarction: are we missing the forest for the trees? Chin CT and Wang TY. Interventional Cardiology. 2009; 1(2): 143-146.
  • End-stage Heart Failure: The Options (Clinical Update). Chin CT and Chuang H-H. SGH Proceedings. 2006; 15(2): 48-60.
  • Availability of Cath Lab Facilities and Contemporary Inter-Hospital Transfer Patterns for the Management of Acute Coronary Syndromes Patients: Findings from the EPICOR Asia Study. Huo Y, Lee S, Sawnhey JPS, Kim HS, Krittayaphong R, Nhan VT, Alonso A, Hayashi N, Zhang L, Han YL, Ge J, Ong TK, Chin CT.
  • Contemporary Pre-Hospital Management of Acute Coronary Syndromes Patients: Results from the EPICOR Asia Study. Huo Y, Lee S, Sawnhey JPS, Kim HS, Krittayaphong R, Nhan VT, Alonso A, Hayashi N, Zhang L, Han YL, Ge J, Chin CT, Ong TK.
  • Platelet Reactivity Measurements before and after Percutaneous Coronary Intervention Among Patients Undergoing Early Invasive Management for Acute Coronary Syndrome. Carvalho L, Chin CT, Teo ZL, Yan B, Huang XR, Troughton R, et al.

Research Trials

  • National Principal Investigator and Steering Committee member for EPICOR-Asia Pacific (an international multi-centre study, with sites from the Asia Pacific region, examining the longitudinal outcomes of patients admitted with acute coronary syndrome) (ongoing)
  • Operational team for the TRILOGY-ACS clinical trial (an international multi-centre randomized controlled trial coordinated by the Duke Clinical Research Institute. http://clinicaltrials.gov/ct2/show/NCT00699998)
  • Catheter-based Renal Sympathetic Denervation for Management of Treatment Resistant Hypertension (ongoing)
  • Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based on the PLATO trial: a Singapore healthcare perspective.
  • Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging- Assessed Ischemia Severity is associated with Mortality Independent of Asian Ethnicity: A Singapore Single-Centre Experience
  • Evaluation of risk factors for cardiovascular events among patients on the cadaveric renal transplant list
  • Operational team for the TRANSLATE-ACS study (a multi-centre study coordinated by the Duke Clinical Research Institute, with sites from the United States, examining the longitudinal outcomes of patients admitted with acute coronary syndrome)
  • Risk stratification and outcomes of patients with prior coronary artery stenting undergoing noncardiac surgery (ongoing)